Zarebska-Michaluk D, Jaroszewicz J, Pabjan P, Lapinski TW, et al. Is an 8-week regimen of glecaprevir/pibrentasvir sufficient for all hepatitis C virus infected patients in the real-world experience? J Gastroenterol Hepatol 2021;36:1944-1952.
PMID: 33171526